Breast Cancer at the Limits 2026
About the event
Registration is now closed and the event takes place for existing delegates on 12th & 13th March. There are no on-site registrations available.
The annual 'Breast Cancer at the Limits' (BCATL) conference is a two-day medical education meeting which brings together a notable faculty of globally acknowledged experts who will consider new scientific discoveries and therapies at the limits of breast cancer research and treatment.
Accreditation
Breast Cancer at the Limits has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 8 category 1 (external) CPD credits.
Audience
This event is solely for HCPs including breast cancer specialists and consultants, researchers, scientists and any medical professionals who have an interest in the treatment of breast cancer.
Registration fee
This event is free to attend.
Travel & Accommodation
For delegates outside the M25 we’ll reimburse accommodation to a maximum of £200, and between £30 (minimum claim) and £100 (maximum claim) for travel. See full conditions at time of registering.
Funders
BCATL is supported by way of grants or sponsorships from the pharmaceutical industry. Our funders have no involvement in the organisation of this event, or the selection of speakers or topics which are handled entirely independently by the event Chairs. Funders are invited to send a delegation of senior company representatives to attend, and their role is simply to continue building the crucial understanding between academia and industry in a scientific setting. Full disclosure of funders is on the event website and available at the venue during the event.
Funders will host pharmaceutical industry promotional satellite symposia. The sessions are clearly marked on the agenda and will be introduced on-site.
Chairs
Contact us
If you require any assistance, please email us
